Level Ventures | Activity | F4
Level Ventures Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
Press
Albert Azout discussed Level Ventures' AI investment thesis with The Sequence, emphasizing application-layer AI over horizontal infrastructure. Albert Azout on the state of AI market and venture investing
Added recently
Participated in an investment round in viaPhoton, a fiber connectivity infrastructure company. Milestone
Portfolio company Enveda Biosciences achieved unicorn status in 2025, approximately 2 years after Level Ventures' initial investment. Enveda Biosciences
Investment
Participated in Enveda Biosciences' $150M Series D alongside Baillie Gifford, Lux Capital, and Premji Invest. Enveda Biosciences
Essay
Published a thesis essay applying Adaptive Markets Theory to VC, arguing that emerging manager alpha requires meaningful portfolio divergence from large platform funds. Smart Alpha vs Beta in VC
New Fund
Filed with the SEC to launch Level Ventures Core Fund II, its second hybrid fund-of-funds and co-investment vehicle. Level Ventures Core Fund II
Investment
Participated in Quantum Source's $50M Series A alongside Dell Technologies Capital, Eclipse, and Grove Ventures. Quantum Source